Generic Drug Review June 2010

Generic Drug Review June 2010

A Review of Treatment Options for Graves' Disease

Graves’ disease is an autoimmune disorder affecting approximately 0.3% of people living in the United States and 0.5% of the world population.

Directions in Generic Drugs

Pharmaceutical companies view branded generics as a valuable commodity, but will economic pressures push consumers toward these products' lower-cost, unbranded counterparts?

Foreign Inspections of Foreign-Made Medications

The agency is stepping up its efforts to ensure that overseas generic as well as brand name drug manufacturers are maintaining the high standards necessary to produce safe, quality products.

Medication Therapy Management: Recommending Generic Drugs as Cost-Savings Substitutes

Assessment of cost concerns is an important aspect of caring for a patient during a medication review.

Trends in Generic Drug Reimbursement in Medicaid and Medicare

Beginning in 2014, millions of additional patients will have access to health care as a result of health care reform legislation, making reimbursements to pharmacists an increasingly important issue.

Continuing Education

$7.95 Per CE Exam or $69 for 12 Lessons